Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared. If approved as a test, doctors might detect cancers sooner and treat them ...

In fact, social isolation is one of the most common, underappreciated side effects of having cancer, and can affect not only a person's mental health, but their ability to fight disease. It can feel ...

CURE asked cancer survivors, thrivers, advocates, and those whose lives have been touched by cancer: what does National Cancer Survivors Month mean to you?

After Matthew Schaefer pulled the blue-and-orange sweater over his head at the NHL draft, his eyes already glistening with ...

As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical ...

Those include lower risk of 10 cancers, protection against heart and kidney diseases, and reduction in systemic inflammation, according to recently published research.

Dr. Joshua Sabari and Jackie Herigodt discuss the Imerman Angels organization and the importance of recognizing the person ...

Our commitment to precision doesn't stop with our medicines. Together with leading urology and oncology experts, Novartis is proud to have built the aptly named PRECISION data platform (PRostatE ...

Cancer (disease) Add Topic. My 5-year-old survived cancer twice. Medical innovation shouldn't be political. | Opinion When you're watching your child battle cancer, every advancement matters.

Search for Symbols, analysts, keywords. Log in. ... The 7 major bladder cancer markets are expected to reach $5.4 billion by 2034. ... With HG-NMIBC patients who had Ta/T1 disease the CRR was 46% ...

Longtime 'SportsCenter' host Jay Harris revealed he was diagnosed with prostate cancer on Thursday, June 5 and encouraged others to get checked for the disease during an appearance on 'Good ...

(RTTNews) - Akeso Inc. announced that the National Medical Products Administration (NMPA) has approved the company's first- in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, for the first ...